ArticleNew microbes and new infections2024
Dengue "homegrown" in Europe (2022 to 2023).
Article in New microbes and new infections, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- Infodemiology of West Nile Virus in Greece, 2024-2025, with Descriptive One Health Preparedness Evidence from Crete.Epidemiologia (Basel, Switzerland) · 2026Article
- Climate Change and Autochthonous Vector-Borne Disease Transmission in Europe: Dengue as a Sentinel Signal for Surveillance and Preparedness.Tropical medicine and infectious disease · 2026Article
- Knowledge, risk perceptions and practices regarding mosquito-borne arboviral diseases among physicians in Baden-Wuerttemberg, Germany: A cross-sectional questionnaire-based analysis.Public health in practice (Oxford, England) · 2026Article
- Epidemiological pattern of dengue infection in South Andaman: a 5-year analysis of primary and secondary infections.European journal of public health · 2026Article
- Autochthonous transmission of dengue in Europe, with special attention to the Spanish context.Epidemiology and infection · 2026Review
- A blood safety perspective on emerging arboviral infections in the United Kingdom.Transfusion medicine (Oxford, England) · 2026Review
- Understanding Mosquito Vector Invasion Pathways: Synergistic Effects of Human Mobility, Climate and Natural Dispersal.Ecology letters · 2026Article
- Dengue virus introduction and 2025 outlook: scenario-based evaluation of vaccination impact using mathematical modeling.Cadernos de saude publica · 2026Article
- Evaluation of VectoMax FG application frequency for the control of Aedes albopictus and Culex species in urban catch basins: evidence from a randomised controlled trial.Parasites & vectors · 2025Article
- Article
- Insecticidal Potential ofPlants (Basel, Switzerland) · 2025Article
- The burden of dengue fever in travellers: a systematic literature review.New microbes and new infections · 2025Review
- Local transmission of arboviral infections in the south of France and prevention paradigms -New microbes and new infections · 2025Article
- Review
- Investigating the impact of endemic mosquitoes and invasive Aedes species on the circulation of Dirofilaria nematodes.Parasites & vectors · 2025Article
- Challenges in Emerging and Reemerging Arboviral Diseases: The Examples of Oropouche and Yellow Fever.Pathogens (Basel, Switzerland) · 2025Article
- Climate, inter-serotype competition and arboviral interactions shape dengue dynamics in Thailand.Communications biology · 2025Article
- Epidemiological and Entomological Study After the Possible Re-Emergence of Dengue Fever in Croatia, 2024.Microorganisms · 2025Article
- Strain-specific quantification ofFrontiers in insect science · 2025Article
- Re-emergence of Oropouche virus as a novel global threat.Current research in microbial sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.